stars 1 stars 2 stars 3

As the successor of BioEqual AG, a pioneer in the development of health products for nail and skin diseases, BioEqual Nova AG builds on a solid legacy and continues this spirit of innovation. For over two decades, BioEqual AG supplied leading brands in the consumer health sector and established significant partnerships. At BioEqual Nova AG, we continue this tradition with a portfolio of solutions for nail and skin problems in pen form. Our Products, based on the unique carrier system of BioEqual, are developed in Switzerland and manufactured in Germany.

BioEqual Questions

The BioEqual annual revenue was $5.3 million in 2026.

Winfried Miller is the Chief Medical Officer of BioEqual.

1 people are employed at BioEqual.

BioEqual is based in Muttenz, Basel-landschaft.

The NAICS codes for BioEqual are [42421, 424, 42, 4242].

The SIC codes for BioEqual are [51, 512].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users